APA (7th ed.) Citation

JS, F., A, B., M, D., AD, F., AD, R., CI, T., . . . W, J. (2022). Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease. Bioorganic & medicinal chemistry letters, 74, 128942. https://doi.org/10.1016/j.bmcl.2022.128942

Chicago Style (17th ed.) Citation

JS, Foot, Buson A, Deodhar M, Findlay AD, Robertson AD, Turner CI, Yow T, Zhou W, and Jarolimek W. "Combining Monoamine Oxidase B and Semicarbazide-sensitive Amine Oxidase Enzyme Inhibition to Address Inflammatory Disease." Bioorganic & Medicinal Chemistry Letters 74 (2022): 128942. https://doi.org/10.1016/j.bmcl.2022.128942.

MLA (9th ed.) Citation

JS, Foot, et al. "Combining Monoamine Oxidase B and Semicarbazide-sensitive Amine Oxidase Enzyme Inhibition to Address Inflammatory Disease." Bioorganic & Medicinal Chemistry Letters, vol. 74, 2022, p. 128942, https://doi.org/10.1016/j.bmcl.2022.128942.